Altay Therapeutics: Funding, Investors & Team (Oct 2026)
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It was founded in 2019 and is headquartered in San Francisco, California.
Altay Therapeutics has raised $40.0M across 2 funding rounds on record, the most recent a Series A of $37.0M announced in Oct 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Altay Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2026.
Altay Therapeutics Funding Rounds
Altay Therapeutics raised $3.0M in a Seed announced in Sep 2022.
4.1 years later, a Series A of $37.0M was announced in Oct 2026.
Altay Therapeutics Investors
14 investors are recorded in total; the 5 named above are those the record identifies.
Altay Therapeutics Founders and Leadership Team
Contact details for the Altay Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Altay Therapeutics Funding Compared to Other Biotechnology Startups
Altay Therapeutics' latest round of $37.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Altay Therapeutics in Biotechnology and San Francisco
Companies Similar to Altay Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Altay Therapeutics Funding FAQs
What does Altay Therapeutics do?
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It was founded in 2019 and is headquartered in San Francisco, California.
How much funding has Altay Therapeutics raised?
Altay Therapeutics has raised $40.0M across 2 rounds on record. The most recent is a Series A of $37.0M announced in Oct 2026.
When did Altay Therapeutics last raise funding?
Altay Therapeutics' most recent funding round on record is a Series A of $37.0M, announced in Oct 2026.
Who has invested in Altay Therapeutics?
Investors on record for Altay Therapeutics include Y Combinator, Sound Bioventures, Creative Destruction Lab, HealthCap, Bossa Invest. FundedIQ records 14 investors in total.
Who founded Altay Therapeutics?
FundedIQ lists Osman Ozes (Founder and Chief Scientific Officer) at Altay Therapeutics.
Who is the CEO of Altay Therapeutics?
Ali Ozes is listed as CEO at Altay Therapeutics.
Where is Altay Therapeutics headquartered?
Altay Therapeutics is based in San Francisco, California, United States.
How many employees does Altay Therapeutics have?
Altay Therapeutics is in the 1-10 employee band.
When was Altay Therapeutics founded?
Altay Therapeutics was founded in 2019.
How does Altay Therapeutics' funding compare to other Biotechnology startups?
Altay Therapeutics' latest round of $37.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Altay Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Altay Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.